How big is the Biomaterials Market | Size & Segments 2025

Code: MTA4809 Publication Date: Jul 2025

What is the size of the Biomaterials Market?

According to 6Wresearch internal database and industry insights, the Biomaterials Market was estimated at USD 171.3 billion in 2024 and is predicted to be USD 331.1 billion by 2031, growing at a CAGR of 9.8% during the forecast period 2025–2031.

Due to increasing demand for advanced medical implants, rising prevalence of chronic diseases, rapid development in tissue engineering, and increasing investments in regenerative medicine and bio-based materials, the market is projected to develop.

Key Growth Factors of the Biomaterials Market

  • Development in biodegradable and bioresorbable materials
  • Surge in orthopaedic, cardiovascular, and dental implant procedures
  • Expanding applications in wound healing, drug delivery, and plastic surgery
  • Increasing adoption of 3D printing using biomaterial filaments
  • Strong government and private funding in healthcare R&D and biocompatible material innovation

Biomaterials Market Trends

The market is growing with the numbers of trends such as the use of natural polymers like collagen, gelatine, and chitosan in regenerative therapies. Further, the smart biomaterials that respond to biological stimuli are gaining attention in drug delivery systems. The integration of biomaterials with 3D bioprinting for tissue and organ scaffolding is increasing. The trend toward sustainable and plant-based biomaterials is emerging in the packaging, cosmetics, and personal care sectors. Nanostructured biomaterials are being developed for targeted therapies and cancer treatment.

Emerging Developments in the Biomaterials Market

Innovation is bringing developments in the market include self-healing materials, bioactive ceramics, and hybrid biomaterials that combine synthetic durability with natural biocompatibility. Now, the companies are focusing on biodegradable implants to eliminate the need for surgical removal.

Collaborations between biotech firms and research institutions are accelerating next-gen biomaterial pipelines, particularly in Europe and the U.S. Asia-Pacific is investing in low-cost biomaterials for scalable healthcare solutions, especially in orthopaedic and dental care.

Major Companies in the Biomaterials Market

  • BASF SE
  • Evonik Industries AG
  • Zimmer Biomet Holdings, Inc.
  • Medtronic PLC
  • Corbion N.V.
  • Covestro AG
  • Johnson & Johnson
  • Collagen Matrix Inc.
  • DSM Biomedical
  • Berkeley Advanced Biomaterials Inc.
How big is the Biomaterials Market : FAQ's
The market was demonstrated around USD 171.3 billion in 2024 and is expected to reach USD 331.1 billion by 2031.
Smart and nanostructured biomaterials, bioprinting applications, plant-based biopolymers, and growth in biodegradable medical products are major trends.
North America leads the market in biomaterial innovation and adoption and Asia-Pacific is emerging market.
High R&D costs, complex regulatory pathways, limited long-term biocompatibility data, and scalability of natural-source biomaterials.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All